Canadian regulators have cleared the sale of an injectable cosmetic wrinkle filler by Suneva Medical, the San Diego company said Wednesday.-
Bellafill, which was approved by Health Canada, is composed of cow collagen, tiny thermoplastic beads and a small amount of the anesthetic Lidocaine.
"The approval of Bellafill is an important milestone in our overall international expansion strategy," said Suneva Chairman and Chief Executive Officer Nicholas Teti.
"We are currently evaluating our options for a Canadian launch," he said. "In addition, we have established international partnership agreements in several countries around the world and expect a number of international product launches later this year."
The product was approved by the Food and Drug Administration in October 2006 for sale in the United States where it is known by the brand name Artefill.
Suneva markets the injection as a longer-lasting alternative to other types of anti-wrinkle shots that require repeated treatments.
The privately owned company was created in April 2009 when Stamford, Conn.-based venture capital firm Cowen Healthcare Royalty Partners acquired Artefill out of bankruptcy from its creator, Artes Medical.
keith.darce@uniontrib.com; (619) 293-1020; Twitter @keithdarce; About Me; Follow us on Facebook or visit the U-T Biotech page.
The San Diego company will sell the shots in Canada under the name Bellafill. — K.C. Alfred
No comments:
Post a Comment